RNS Number:0479S
Celsis International PLC
5 October 2000


Announces Appointment of New Finance Director

Celsis International plc is today pleased to announce the appointment of Mr
Christian Madrolle as Finance Director.

Mr Madrolle joins Celsis with more than 31 years international experience in
finance and administration, most recently with the French Company Biocom, the
main business of which is the supply of microbial monitoring instrumentation
to the dairy sector world-wide.

Mr Madrolle previously held a variety of positions with Xerox, Transport
International and Portacabin.  Mr Madrolle began his career at Xerox in 1969,
where he became Finance and Administration Manager for the Paris region.  He
then joined Portacabin with the remit to establish a French subsidiary,
firstly as General Manager, and then as Director in 1975.  In 1981 Mr Madrolle
joined Transport International (Amsterdam) as European Finance Director, and
in 1982 was asked back by Portacabin to take up the position of General
Manager for the European Division.  Mr Madrolle became a main Board Director
of Portacabin Ltd in 1985 with responsibility for the European operation.

Dr Jack Rowell commented: 
"I am pleased to announce the appointment of Christian Madrolle who arrives at
an important stage in the development of the Company.  His many years of
international experience in finance and administration, and his insight into
the microbial testing and Dairy industry will be invaluable to us as we seek
to expand and develop the business.  I look forward to working with him as we
take the business forward."

Enquiries
Celsis International plc     Jack Rowell, Chief Executive   +44-1223-426008
Brunswick                    Melissa Miller                 +44-207-404-5959

Notes to Editors

Celsis International plc

Celsis International plc specialises in the development and supply of rapid
diagnostic and monitoring systems to detect and measure microbial
contamination.  It has successfully developed tests for use in the food,
beverage, pharmaceutical, cosmetic and toiletries industries.  These tests are
based upon the technology of ATP Bioluminescence; such tests detect the
presence of microbial contamination by monitoring light emitted when adenosine
triphosphate ("ATP"), a naturally occurring substance present in all living
organisms, is brought into contact with luciferase, an enzyme produced by
fireflies.
Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Celadon Pharmaceuticals Charts.
Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Celadon Pharmaceuticals Charts.